patent no. 5298520 expired
Merck may take up Rizatriptan film from Intelgenx to extend the lifecycle, good opportunity here
I don't know where you're getting your information... The migraine drug (Rizatriptan) is already partnered with Redhill Biopharma and the NDA will be filed with the FDA this quarter!
Sentiment: Strong Buy
Redhill Bio is development partner (manufacturing stuff, like they have it with Pillar5 pharma for forfivo XL) and not marketing partner (like edgemont pharma).
What percentage belong to Intelgenx if Merck take Rizatriptan film ? The NDA will easy to pass from FDA.............
it can be doule digit % royalty on sales (like they have for Forfivo XL) or it can be a onetime lump-sum (like UCB paid 11 million $ to Alembic for Keppra XR )
I thought about this last night.
If what you are suggesting is feasible, why doesn't MRK or any other Big Pharma buyout IGXT completely.
To me, $5 billion ($100/share) is a bargain to avoid LOE on a group of blockbusters.